CXCR4 is a cell-surface receptor that has been described as being overexpressed in more than 20 cancer types, including hematologic and solid neoplasias [7,8,9], and is the chemokine receptor most commonly expressed by cancer cells [10]. Here, CD177 is linked to cancer.